These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 32386280)

  • 41. Hematopathologists and cytopathologists: enemies or allies?
    Young NA; Al-Saleem T
    Diagn Cytopathol; 1999 Nov; 21(5):305-6. PubMed ID: 10527474
    [No Abstract]   [Full Text] [Related]  

  • 42. Symposium part 3: Should pathologists diagnose endocervical preneoplastic lesions "less than" adenocarcinoma in situ?: Point.
    Ioffe OB; Sagae S; Moritani S; Dahmoush L; Chen TT; Silverberg SG
    Int J Gynecol Pathol; 2003 Jan; 22(1):18-21. PubMed ID: 12496692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The promise and risk of a new technology: the Lehigh Valley Hospital's experience with liquid-based cervical cytology.
    Beckwith DG; Shane JJ; Dupree WB
    Cancer; 1998 Oct; 84(5):317-8. PubMed ID: 9801207
    [No Abstract]   [Full Text] [Related]  

  • 44. The utilization and utility of immunostains in body fluid cytology.
    Alshaikh S; Lapadat R; Atieh MK; Mehrotra S; Barkan GA; Wojcik EM; Pambuccian SE
    Cancer Cytopathol; 2020 Jun; 128(6):384-391. PubMed ID: 32163239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of the programme for cytological detection of cancer of the cervix in Berlin (R.D.A.) (author's transl)].
    Berndt H; Neuser D; Ebeling K
    Bull Cancer; 1979; 66(4):407-8. PubMed ID: 526629
    [No Abstract]   [Full Text] [Related]  

  • 46. Using a web-based system for the continuous distance education in cytopathology.
    Stergiou N; Georgoulakis G; Margari N; Aninos D; Stamataki M; Stergiou E; Pouliakis A; Karakitsos P
    Int J Med Inform; 2009 Dec; 78(12):827-38. PubMed ID: 19775933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Critical values in anatomic pathology: how do we communicate?
    LiVolsi VA
    Am J Clin Pathol; 2004 Aug; 122(2):171-2. PubMed ID: 15323131
    [No Abstract]   [Full Text] [Related]  

  • 48. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
    Renshaw AA; Deschênes M; Auger M
    Am J Clin Pathol; 2009 Jun; 131(6):776-81. PubMed ID: 19461082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distance assisted training in sub-Saharan Africa: a program evaluation.
    Philotheou GM
    J Nucl Med Technol; 2004 Sep; 32(3):166-70. PubMed ID: 15347696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytotechnologist-attended on-site evaluation of adequacy for metastatic disease involving bone and soft tissue.
    Olson MT; Novak A; Kirby J; Shahid H; Boonyaarunnate T; Ali SZ
    Acta Cytol; 2013; 57(6):550-6. PubMed ID: 24107299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
    Moodley J; Constant D; Botha MH; van der Merwe FH; Edwards A; Momberg M
    BMC Womens Health; 2019 Jan; 19(1):2. PubMed ID: 30616579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP).
    Nielsen ML
    Arch Pathol Lab Med; 1997 Mar; 121(3):256-9. PubMed ID: 9111112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Potentialities of the cytological method of studying the cervical canal in early forms of cervical cancer].
    Novikova EG; Sorokin SZ; Shabalova IP
    Lab Delo; 1987; (11):834-6. PubMed ID: 2448529
    [No Abstract]   [Full Text] [Related]  

  • 54. Telepathology: a tool to aid in diagnosis and quality assurance in cervicovaginal cytology.
    Marsan C; Vacher-Lavenu MC
    Cytopathology; 1995 Oct; 6(5):339-42. PubMed ID: 8785372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New terminology for intrauterine endometrial samples: a group study by the Japanese Society of Clinical Cytology.
    Yanoh K; Hirai Y; Sakamoto A; Aoki D; Moriya T; Hiura M; Yamawaki T; Shimizu K; Nakayama H; Sasaki H; Tabata T; Ueda M; Udagawa Y; Norimatsu Y
    Acta Cytol; 2012; 56(3):233-41. PubMed ID: 22555523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tennis racket cells in severe dyskaryosis in hyperchromatic crowded cell groups of SurePath(TM) cervical samples.
    Gupta N; Desai M; Hermansen P; Davies J
    Cytopathology; 2013 Apr; 24(2):136-8. PubMed ID: 22230007
    [No Abstract]   [Full Text] [Related]  

  • 57. Informal mobile learning in nurse education and practice in remote areas--a case study from rural South Africa.
    Pimmer C; Brysiewicz P; Linxen S; Walters F; Chipps J; Gröhbiel U
    Nurse Educ Today; 2014 Nov; 34(11):1398-404. PubMed ID: 24745478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Andrology and accreditation - An opportunity for Cytologists.
    Holland L; Maddox A
    Cytopathology; 2019 Nov; 30(6):650-652. PubMed ID: 31400165
    [No Abstract]   [Full Text] [Related]  

  • 59. Digital pathology for the primary diagnosis of breast histopathological specimens: an innovative validation and concordance study on digital pathology validation and training.
    Williams BJ; Hanby A; Millican-Slater R; Nijhawan A; Verghese E; Treanor D
    Histopathology; 2018 Mar; 72(4):662-671. PubMed ID: 28940580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Automation in cervical cancer screening--part 2: flow systems and other techniques.
    Husain OA; Tucker JH; Roberts BA
    Biomed Eng; 1976 Jun; 11(6):204-10. PubMed ID: 949513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.